Show simple item record

Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer

dc.contributor.authorYildirmak, Yildiz
dc.contributor.authorKARAMAN, SERAP
dc.contributor.authorUrganci, Nafiye
dc.contributor.authorUsta, Merve
dc.contributor.authorVural, Sema
dc.date.accessioned2021-03-06T13:09:31Z
dc.date.available2021-03-06T13:09:31Z
dc.date.issued2011
dc.identifier.citationKARAMAN S., Vural S., Yildirmak Y., Urganci N., Usta M., "Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer", ANNALS OF SAUDI MEDICINE, cilt.31, ss.573-576, 2011
dc.identifier.issn0256-4947
dc.identifier.otherav_f7421fa5-4790-4c95-a523-1a8506fdfae3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/161996
dc.identifier.urihttps://doi.org/10.4103/0256-4947.87091
dc.description.abstractBACKGROUND AND OBJECTIVES: Hepatitis B is a disease that is preventable with vaccination. Antibody levels after vaccination may be affected by suppression of the immune system due to cancer therapy. Children with cancer have a high risk of hepatitis B virus (HBV) infection. We aimed to assess the pretreatment immunization status against HBV infection and the rate of continuity of immunization after therapy in children with cancer.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectTemel Tıp Bilimleri
dc.titleAssessment of hepatitis B immunization status after antineoplastic therapy in children with cancer
dc.typeMakale
dc.relation.journalANNALS OF SAUDI MEDICINE
dc.contributor.departmentIstanbul Sisli Hamidiye Etfal Training & Research Hospital , ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage573
dc.identifier.endpage576
dc.contributor.firstauthorID728888


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record